Ali Mohamed

Company: Immatics

Job title: SVP of CMC

Seminars:

Developing Next-Generation Allogeneic Therapies for Solid Tumors Based on Gamma Delta T cells 4:30 pm

Discussing characteristics of gamma delta T cells as source for an allogeneic cell therapy approach Redirecting gamma delta T cells with TCRs against peptide-HLA targets to combat solid tumors Exploring next-gen strategies to potentiate anti-tumor activityRead more

day: Day Two